Molecular Imaging

Researchers from Columbia University in New York have developed a molecular imaging tool that can track metabolic changes in individual living cells in real time, according to research published July 30 in Nature Communications.

Researchers from the Keck School of Medicine at the University of Southern California (USC) successfully used high-resolution MRI and a cell-labeling technique to visualize nearly 100 cells, which may allow clinicians to assess the effectiveness of immune cell- and stem cell-based therapies to treat cancer.

For patients with metastatic prostate cancer, understanding its genesis and evolution can mean all the difference for treatment. But, what if, as a recent Journal of Nuclear Medicine perspective proposes, a new “clinical state” could improve understanding and treatment of the disease?

The Society for Nuclear Medicine and Molecular Imaging (SNMMI), along with a host of other leading medical imaging groups and vendors, addressed a July 18 letter to the Senate and House subcommittees on Energy and Water Development voicing its support for $20 million in additional funding to help establish domestic production of molybdenum-99 (Mo-99).

A team from the University of Wisconsin-Madison successfully used PET imaging to visualize heart damage commonly seen in those with Parkinson’s disease. The technique will help develop therapies.

The shutdown of Australia’s sole nuclear medicine generator due to mechanical problems is beginning to impact patient treatment, particularly for individuals in rural parts of the country, the Guardian reported.

A novel PET imaging method may improve evaluation of joint inflammation in rheumatoid arthritis patients by targeting translocator protein (TSPO) expression in joint lining tissue, according to research published online in the July issue of The Journal of Nuclear Medicine.

A team of researchers has created a virtual reality (VR) environment that allows users to manipulate 3D molecular proteins 10 times faster than with a 2D screen, according to a July 3 article by the New York Times.

Adding fluorine-18 (18F)-fluciclovine PET/CT to the diagnostic treatment plan of patients with biochemical recurrence of prostate cancer can identify previously undetected lesions and alter treatment management for patients with the disease.

European researchers have developed a robust macroscale imaging technique based on florescence lifetime imaging microscopy (FLIM) that can analyze cellular processes up to four centimeters in size.

Researchers—led by Kevin Chen, PhD, a postdoctoral fellow at Harvard University's Microrobotics Lab—have found that spatiotemporally correlated data acquired using a single magnetic resonance (MR) sequence may be successfully used in a PET/MRI scanner for PET attenuation, motion and partial effects corrections.

A new group of officers has been selected at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2018 annual meeting, including president Satoshi Minoshima, MD, PhD, professor and chair of the department of radiology and imaging sciences at the University of Utah in Salt Lake City.